Member Info for JimiHendrix

Once it’s profitable it could move up on to the main market.

My guess is they'll raise £5m, plus they still have an additional £1.5m from RF so that would keep them going for a decent amount of time and include enough for the FDA deal. Hopefully good news comes before they agree a raise, personally I think it will.

"In line with specialist commissioning being devolved to the Integrated Care Boards ("ICBs"), our initial discussions have been with the Manchester ICB to obtain funding from April 2024 for the live sites across the Greater Manchester region."

If they're successful with that then presumably it would be announced next week, most likely before funding is organised (coming weeks).

Crooty, RF was not the only option at 30p. They said in the RNS there were other options. My opinion is they probably didn't realise the negative effect the RF deal would have over time.

No official shorts but if a broker wants to maybe they can simply sell shares that they have in any of their client's accounts and then buy them back. Risky perhaps, but maybe not so risky if it's a company's nominated broker who can instruct the company on which news to release or not release. Surely that wouldn't be possible though within a tightly regulated market! ...all in my imagination I'm sure lol.

3.4p to buy currently, market makers don't seem to want to sell many shares cheaper than this... could buy at 3p for a moment and then after a few buys it ticks up 15%.

The question in my mind is will the advanced stage FDA deal and specialist commissioning for Manchester hospitals (potentially from April) be finalised and announced before the funding is agreed... bearing in mind they could stretch out the runway to end of August if they take up the remaining facility drawdowns (by mutual agreement). Which would then open the timeframe to receiving the stroke marker NICE recommendation... another big shareprice driver.

I also think there's a strong chance PH or RF have been shorting this and if so could flip anytime now imo.

Strange that the US distributor wasn't announced like the European/ME ones were. My guess is Peel told them not to disclose it yet knowing that it would've sent the share price up.

Current cash runway until the end of May, however they also have £1.5m still available in the facility to drawdown if they need.

Specialist commissioning potentially coming to Manchester hospitals next month. If that comes before funding then the share price will be much higher.

Lol major deramping effort in force at the moment. I’m not making it up, I’m away at the moment but if I find time I guess I’ll have to prove it. Off the top of my head I think it was said in one of the investor meet presentations or the circular. They had other funding options but believed that was the best.

They went with the RF deal because it appeared to be the best for the share price, they believer there would be enough positive news to keep the share price high… avoiding the death spiral effect. They had traditional placing deals on the table too, but chose that. Initially it did seem to be a good deal. But with all the NICE delays the share price slid under 16p and then further causing much more dilution than there would have been.

Regarding this year, they didn’t need to raise earlier in the year - they made it very clear in the last presentation their cash runway would be extended if they received other funding (which they did via RF).

He said he hoped to update us early 2024 on the FDA partners deal. January was mentioned regarding NICE, but we know NICE delayed.

That may have been a delayed sell, something caused the share price to drop earlier this afternoon after a few big buys it was weird... suddenly dropped about 5%... which then triggered sells.

Must have been a large background sell this afternoon, the BID/ASK suddenly dropped despite some hefty buys.

Glad to see NICE have updated the publishing date at last, well spotted Nissan.

Including the £1.5m remaining in the facility to drawdown under mutual agreement and the £1.2m they currently have they have enough cash to cover the monthly burn rate for over 6 months.

When support is being tested and a reversal begins it can take a load of buys before the share price actually moves, like a coiled spring the pressure builds up and then it moves up quickly and easily. Especially if there is positive news expected in the coming days.

If true, at a premium to the current share price I would imagine.

I’m expecting some positive news next week on various points. Further adoption sites, FDA partner update, stroke marker test trialling in Manchester and possible sells for research use in Europe, NICE and the big one for me… specialist commissioning… which I think will begin in the new financial year in a couple of weeks time.

Https://www.england.nhs.uk/long-read/annex-1-services-suitable-for-delegation-in-2024-25/

Specialised commissioning 2024/25 -

Services suitable for delegation in 2024/25...

"118 - Neonatal critical care services - NIC - Specialist neonatal care services"

AIHL test will be in there surely.